Delivering support through every stage of the pharmaceutical lifecycle
As leaders in API development and manufacturing, we support our customers’ projects from discovery to full commercial manufacture, while providing them access to emerging technologies, new efficiencies, and complete continuity along the way. Our customers include global pharmaceutical corporations and innovative biotechs, both of which have unique challenges and priorities at each stage of the complex molecule lifecycle.
Molecule lifecycle services at Sterling
With the rising complexity of APIs in the pipeline today, complete project continuity has become increasingly critical to proactively address challenges, enhance efficiency, minimise costs, streamline development and manufacturing, and accelerate time to market. As a result, pharmaceutical and biotechnology organisations require an outsourced partner with the capabilities to support their product throughout its entire lifecycle, from grams to tonnes. ... Read more
As a full service PDMO®, or partnership development and manufacturing organisation, we have extensive expertise supporting our customers’ molecules from the earliest phases of discovery through to full commercial manufacture. In our global delivery network, our customers will find the world-class facilities, specialised equipment, and highly skilled team members they need to address a wide range of project requirements at every stage—all while benefiting from our simple way of working, our commitment to integrity, and our true scientific collaboration. Read less
Here’s how we accelerate your product’s path to market by delivering unrivalled support at every stage of the pharmaceutical lifecycle.
As many drugs in the pipeline fail to progress past phase II trials, phase III is a significant milestone for our customers and their products. In this critical phase, we work to finalise data generation and process validation, and to prepare in earnest for full commercial manufacture. Scale, efficiency, quality control, integrity, and compliance are all top priorities as we navigate the last phase prior to commercial launch.
Technologies & Services
At Sterling we have extensive API Development capabilities ranging from route scouting and design,…
As small molecule complexity continues to rise, we deliver our customers the scientific and…
With more than 50 years’ expertise in hazardous chemistry, we offer the specialised knowledge,…
From pre-clinical CMC strategies to regulatory filings and post launch process improvement efforts,…
High Potency APIs
With more drugs than ever classified as highly potent under development today, we are uniquely…
Our comprehensive controlled substance services are supported by robust analytical expertise,…
Knowledge Hub Articles